Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Neutrally Charged Diarylurea Compound PQ401 Kills Antibiotic-Resistant and Antibiotic-Tolerant Staphylococcus aureus

mBio(2020)10.1128/mbio.01140-20Source: DataRank Database

The Neutrally Charged Diarylurea Compound PQ401 Kills Antibiotic-Resistant and Antibiotic-Tolerant Staphylococcus aureus is a research paper published in mBio (2020). On theSindex it has a DataRank of 0. It has been cited 53 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access53 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 4.44)OA: goldTopics (72)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Guijin Zou ORCID,Wen Pan ORCID,Nico Fricke,Hammad A. Faizi ORCID,Soo Min Kim ORCID

Live enrichment

PubMed:32605985 PMC:PMC7327171 OpenAlex:https://openalex.org/W3040183361

HHS | National Institutes of Health

Grant: P01AI083214

National Research Foundation of Korea

Grant: 2020R1C1C1008842

National Research Foundation of Korea

Grant: 2018R1A5A2025286

National Research Foundation of Korea

Grant: 2017M3A9E4077234

National Institutes of Health

Grant: 5P01AI083214-10

Harvard-wide Program on Antibiotic Resistance

Agency for Science, Technology and Research

FWCI

4.44

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1128/mbio.01140-20

GOLDhttps://doi.org/10.1128/mbio.01140-20

publisherhttps://doi.org/10.1128/mbio.01140-20

publisherhttps://journals.asm.org/doi/pdf/10.1128/mBio.01140-20

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32605985

Fields of Study

Antimicrobial Peptides and ActivitiesAntimicrobial agents and applicationsBioactive Compounds and Antitumor AgentsMedicineChemistry0301 basic medicine03 medical and health sciencesAminoquinolinesAnimalsAnti-Bacterial AgentsCaenorhabditis elegansDrug SynergismGentamicinsHemolysisHumansLarvaMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsMolecular Dynamics SimulationMothsPhenylurea CompoundsStaphylococcal InfectionsStaphylococcus aureus

MeSH Terms

AminoquinolinesAnimalsAnti-Bacterial AgentsDrug SynergismGentamicinsHemolysisHumansLarvaMicrobial Sensitivity TestsMothsPhenylurea CompoundsStaphylococcal InfectionsStaphylococcus aureusCaenorhabditis elegansMethicillin-Resistant Staphylococcus aureusMolecular Dynamics Simulation

Keywords

AntibioticsStaphylococcus aureusMicrobiologyAntibiotic resistanceBacteriaMedicineBiologyAntibioticCaenorhabditis elegansAntimicrobial resistanceMRSAAntibiotic TolerancePersistersMembrane-active AgentBacterial PersisterMembrane-active AntimicrobialsMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsMolecular Dynamics SimulationMothsHemolysisEngineering::Mechanical engineeringAnimalsHumansPhenylurea CompoundsDrug SynergismStaphylococcal InfectionsQR1-502Anti-Bacterial AgentsLarvaAminoquinolinesGentamicinsResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being